Clinical characteristics of imported cases of coronavirus disease 2019 (COVID-19) in Jiangsu Province: A multicenter descriptive study

Clinical Infectious Diseases

Volumn 71, Issue 15, 2020, Pages 706-712

  Wu, Jian ^a,b   Liu, Jun ^c   Zhao, Xinguo ^c   Liu, Chengyuan ^b   Wang, Wei ^b   Wang, Dawei ^d   Xu, Wei ^e   Zhang, Chunyu ^d   Yu, Jiong ^a   Jiang, Bin ^f   Cao, Hongcui ^a,g   Li, Lanjuan ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b Department of Respiratory Medicine The First People s Hospital of Yancheng City   (China)

^c JIANGNAN UNIVERSITY   (China)

^d The Second People's Hospital of Yancheng City   (China)

^e JIANGSU UNIVERSITY   (China)

^f Seismological Station of Yancheng   (China)

^g Laboratory of Diagnosis and Treatment of Cardiovascular Disease Zhejiang Province   (China)

Author keywords

Clinical characteristics; Coronavirus disease 2019 (COVID 19); Imported cases; Pneumonia

Indexed keywords

IMMUNOGLOBULIN; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MOXIFLOXACIN; RIBAVIRIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CHINA; CHINESE MEDICINE; CHRONIC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CORONAVIRUS DISEASE 2019; COUGHING; DIARRHEA; DYSPNEA; EXTRACORPOREAL OXYGENATION; FEMALE; FEVER; HEADACHE; HEMODIALYSIS; HEMOPTYSIS; HORMONAL THERAPY; HOSPITAL; HOSPITAL DISCHARGE; HUMAN; IMAGING; LENGTH OF STAY; LIVER DYSFUNCTION; LUNG PARENCHYMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; MYALGIA; NAUSEA AND VOMITING; NOSE SMEAR; PLEURA EFFUSION; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; REAL TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; RHINORRHEA; SORE THROAT; SYMPTOM; THORAX PAIN; THROAT CULTURE; VIRUS DETECTION; WORLD HEALTH ORGANIZATION; YOUNG ADULT; ADOLESCENT; BETACORONAVIRUS; CLINICAL TRIAL; CORONAVIRUS INFECTION; LUNG; PANDEMIC; PATHOGENICITY; PATHOLOGY; VIROLOGY; VIRUS PNEUMONIA;

ADOLESCENT; ADULT; AGED; BETACORONAVIRUS; CHINA; CORONAVIRUS INFECTIONS; COUGH; FEMALE; FEVER; HUMANS; LUNG; MALE; MIDDLE AGED; PANDEMICS; PATIENT DISCHARGE; PNEUMONIA, VIRAL; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 85082664795     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciaa199     Document Type: Article

References (27)

1. Peng Z, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; doi:10.1038/s41586-020-2012-7.
2. Zhao S, Lin Q, Ran J, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. Int J Infect Dis 2020; 92: 214-7.
3. Thompson RN. Novel coronavirus outbreak in Wuhan, China, 2020: intense surveillance is vital for preventing sustained transmission in new locations. J Clin Med 2020; 9: doi:10.3390/jcm9020498.
4. Liu Y, Gayle AA, Wilder-Smith A, et al. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med 2020; doi:10.1093/jtm/ taaa021.
5. Hui DS, Azhar EI, Kim Y-J, et al. Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission. Lancet Infect Dis 2018; 18:e217-e227.
6. Cho SY, Kang J-M, Ha YE, et al. MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study. Lancet 2016; 388:994-1001.
7. Chen L, Liu W, Zhang Q, et al. RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak. Emerg Microbes Infect 2020; 9:313-319.
8. Du Z, Wang L, Cauchemez S, et al. Risk for transportation of 2019 novel coronavirus disease from Wuhan to other cities in China. Emerging Infect Dis 2020; 26: doi:10.3201/eid2605.200146.
9. Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020; 395: 565-74.
10. Kofi Ayittey F, Dzuvor C, Kormla Ayittey M, et al. Updates on Wuhan 2019 novel coronavirus epidemic. J Med Virol 2020; 92: 403-7.
11. Kanne JP. Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist. Radiology 2020; doi:10.1148/ radiol.2020200241.
12. Yu F, Du L, Ojcius DM, et al. Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan. China. Microbes Infect 2020; doi:10.1016/j.micinf.2020.01.003.
13. Eurosurveillance Editorial Team. Note from the editors: World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern. Euro Surveill. 2020; 25. doi: 10.2807/1560-7917. ES.2020.25.5.200131e.
14. World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance. 2020. Available at: https://www.who.int/internalpublications-detail/clinicalmanagement-of-severe-acute-respiratoryinfection-when-novel-coronavirus(ncov)-infection-is-suspected. Accessed 20 January 2020.
15. Yang F, Liu N, Wu JY, et al. Pulmonary rehabilitation guidelines in the principle of 4S for patients infected with 2019 novel coronavirus (2019-nCoV). Zhonghua Jie He He Hu Xi Za Zhi 2020; 43:E004.
16. Chen Z-M, Fu J-F, Shu Q, et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Pediatr 2020; doi:10.1007/s12519-020-00345-5.
17. Tuite AR, Fisman DN. Reporting, epidemic growth, and reproduction numbers for the 2019 novel coronavirus (2019-nCoV) epidemic. Ann. Intern. Med 2020; doi:10.7326/M20-0358.
18. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395: 507-13.
19. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506.
20. Song F, Shi N, Shan F, et al. Emerging coronavirus 2019-nCoV pneumonia. Radiology 2020; doi:10.1148/radiol.2020200274.
21. Wan Y, Shang J, Graham R, et al. Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. J. Virol 2020; doi:10.1128/JVI.00127-20.
22. Chai X, Hu L, Zhang Y, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv 2020; doi: https://doi.org/10.1101/2020.02.03.931766
23. Chung M, Bernheim A, Mei X, et al. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology 2020; doi:10.1148/radiol.2020200230.
24. Liu W, Morse Jared S, Lalonde T, et al. Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV. Chembiochem 2020; 21: 730-8.
25. Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends 2020; doi:10.5582/bst.2020.01020.
26. Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med 2020; 382: 929-36.
27. Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020; 30: 269-71.